<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Proc Natl Acad Sci U S A</journal-id>
<journal-id journal-id-type="iso-abbrev">Proc. Natl. Acad. Sci. U.S.A</journal-id>
<journal-id journal-id-type="hwp">pnas</journal-id>
<journal-id journal-id-type="pmc">pnas</journal-id>
<journal-id journal-id-type="publisher-id">PNAS</journal-id>
<journal-title-group>
<journal-title>Proceedings of the National Academy of Sciences of the United States of America</journal-title>
</journal-title-group>
<issn pub-type="ppub">0027-8424</issn>
<issn pub-type="epub">1091-6490</issn>
<publisher>
<publisher-name>National Academy of Sciences</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27140629</article-id>
<article-id pub-id-type="pmc">4878475</article-id>
<article-id pub-id-type="publisher-id">201603282</article-id>
<article-id pub-id-type="doi">10.1073/pnas.1603282113</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>PNAS Plus</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Biological Sciences</subject>
<subj-group>
<subject>Biochemistry</subject>
</subj-group>
</subj-group>
<series-title>PNAS Plus</series-title>
</article-categories>
<title-group>
<article-title>Control of serotonin transporter phosphorylation by conformational state</article-title>
<alt-title alt-title-type="short">Conformation controls SERT phosphorylation</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Yuan-Wei</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Turk</surname>
<given-names>Benjamin E.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-7622-4110</contrib-id>
<name>
<surname>Rudnick</surname>
<given-names>Gary</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>1</sup>
</xref>
</contrib>
<aff id="aff1"><sup>a</sup>Department of Pharmacology, <institution>Yale University School of Medicine</institution>, New Haven, <addr-line>CT</addr-line> 06520</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><sup>1</sup>To whom correspondence should be addressed. Email: <email>gary.rudnick@yale.edu</email>.</corresp>
<fn fn-type="edited-by">
<p>Edited by H. Ronald Kaback, University of California, Los Angeles, CA, and approved April 4, 2016 (received for review February 26, 2016)</p>
</fn>
<fn fn-type="con">
<p>Author contributions: B.E.T. and G.R. designed research; Y.-W.Z. performed research; Y.-W.Z. and G.R. analyzed data; and B.E.T. and G.R. wrote the paper.</p>
</fn>
<fn fn-type="conflict">
<p>The authors declare no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>17</day>
<month>5</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>2</day>
<month>5</month>
<year>2016</year>
</pub-date>
<volume>113</volume>
<issue>20</issue>
<fpage>E2776</fpage>
<lpage>E2783</lpage>
<permissions></permissions>
<self-uri xlink:href="pnas.201603282.pdf" xlink:title="pdf"></self-uri>
<abstract abstract-type="executive-summary">
<title>Significance</title>
<p>Mutations in serotonin transporter (SERT) affecting regulation of a cGMP-dependent signaling pathway have been associated with psychiatric disorders. Earlier studies provided preliminary evidence that cGMP stimulates phosphorylation of SERT in a transmembrane helix. Transporters like SERT function by undergoing a cycle of conformational changes as they move their substrate (in this case the neurotransmitter 5-HT) across the membrane. This work shows that SERT conformation dramatically affects phosphorylation, which is stimulated when the transporter is in a conformation known to increase during 5-HT transport. The results suggest a novel mechanism of regulation in which transport of 5-HT increases the level of an inward-open SERT conformation that provides accessibility of the phosphorylation site to a kinase.</p>
</abstract>
<abstract>
<p>Serotonin transporter (SERT) is responsible for reuptake and recycling of 5-hydroxytryptamine (5-HT; serotonin) after its exocytotic release during neurotransmission. Mutations in human SERT are associated with psychiatric disorders and autism. Some of these mutations affect the regulation of SERT activity by cGMP-dependent phosphorylation. Here we provide direct evidence that this phosphorylation occurs at Thr276, predicted to lie near the cytoplasmic end of transmembrane helix 5 (TM5). Using membranes from HeLa cells expressing SERT and intact rat basophilic leukemia cells, we show that agents such as Na<sup>+</sup> and cocaine that stabilize outward-open conformations of SERT decreased phosphorylation and agents that stabilize inward-open conformations (e.g., 5-HT, ibogaine) increased phosphorylation. The opposing effects of the inhibitors cocaine and ibogaine were each reversed by an excess of the other inhibitor. Inhibition of phosphorylation by Na<sup>+</sup> and stimulation by ibogaine occurred at concentrations that induced outward opening and inward opening, respectively, as measured by the accessibility of cysteine residues in the extracellular and cytoplasmic permeation pathways, respectively. The results are consistent with a mechanism of SERT regulation that is activated by the transport of 5-HT, which increases the level of inward-open SERT and may lead to unwinding of the TM5 helix to allow phosphorylation.</p>
</abstract>
<kwd-group>
<kwd>serotonin</kwd>
<kwd>transporter</kwd>
<kwd>phosphorylation</kwd>
<kwd>conformation</kwd>
<kwd>ibogaine</kwd>
</kwd-group>
<funding-group>
<award-group id="gs1">
<funding-source id="sp1">HHS | NIH | National Institute on Drug Abuse (NIDA)<named-content content-type="funder-id">100000026</named-content></funding-source>
<award-id rid="sp1">7259</award-id>
<award-id rid="sp1">8213</award-id>
</award-group>
<award-group id="gs2">
<funding-source id="sp2">HHS | NIH | National Institute of General Medical Sciences (NIGMS)<named-content content-type="funder-id">100000057</named-content></funding-source>
<award-id rid="sp2">104047</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="8"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>